Profitability Ratios
| Ratio |
Value |
| GP Margin |
55.5% |
| EBIT Margin |
19.9% |
| EBITDA Margin |
26.1% |
| Operating Margin |
18.2% |
| Pretax Margin |
19.1% |
| Cont. Ops Margin |
14.7% |
| Net Margin |
14.7% |
| Bottom Line Margin |
14.7% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.58 |
| Quick Ratio |
1.18 |
| Solvency Ratio |
0.273 |
| Cash Ratio |
0.52 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.65 |
| Forward PEG |
-0.65 |
| Price/Book |
4.20 |
| Price/Sales |
4.94 |
| Price/FCF |
29.60 |
| Price/Op Cash Flow |
22.88 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1738 |
| Debt/Equity |
0.2890 |
| Debt/Capital |
0.2242 |
| Long-Term Debt/Capital |
0.1720 |
| Financial Leverage |
1.66 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
4.67 |
| Operating Cash Flow Ratio |
0.580 |
| Operating Cash Flow/Sales |
21.6% |
| Free Cash Flow/Operating Cash Flow |
77.3% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.63 |
| Interest Coverage |
23.6012 |
| Short-Term Operating Cash Flow Coverage |
2.89 |
| Operating Cash Flow Coverage |
0.63 |
| Capital Expenditure Coverage |
4.41 |
| Dividend + Capital Expenditure Coverage |
1.52 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
63.0901% |
| Dividend Yield |
1.8805% |
| Dividend Yield % |
1.8805% |
| Dividend Per Share |
2.3560 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
25.37 |
| EPS |
3.734 |
| Debt/Share |
8.8197 |
| Cash/Share |
5.12 |
| Book Value/Share |
30.21 |
| Tangible BV/Share |
13.29 |
| Equity/Share |
29.84 |
| Operating Cash Flow/Share |
5.476 |
| Capital Expenditure/Share |
1.243 |
| FCF/Share |
4.233 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.771 |
| Earnings Before Tax/EBIT |
1.052 |
| Price/Fair Value |
4.20 |
| Debt/Market Cap |
0.0646 |
| Effective Tax Rate |
22.9% |
| Enterprise Value Multiple |
19.51 |
ABT - Abbott Laboratories